As part of DCVMN’s continued efforts to strengthen partnerships and elevate the role of vaccine manufacturers in developing countries, our CEO Rajinder Suri recently concluded a strategic visit to China, where he met with the leadership of several DCVMN member companies: AIM Vaccine Co.,Ltd.; CNBG (Sinopharm); Kangtai Biological Products Co., Ltd.(MinHai); Chongqing Zhifei Biological Products Co., Ltd. Ably supported by Mr. Andrew Wong, DCVMN Board member and Senior Advisor, Corporate Board, Walvax.
These meetings provided an opportunity to listen closely to each company’s needs, exchange ideas, and explore how DCVMN can further support their efforts to build a more resilient and equitable global vaccine ecosystem. From sharing updates on manufacturing pipelines and distribution strategies to discussing new areas for expansion and partnerships, the conversations were rich in insight and forward-looking collaboration.
Mr. Suri provided tailored advice on pathways to WHO prequalification, offered strategic perspectives on vaccine combinations that could better align with the needs of global procurers like UNICEF, Pan American Health Organization and Gavi, the Vaccine Alliance, and explored opportunities for South-South collaborations to scale up manufacturing capacity.
Chinese member companies expressed a strong desire to expand their international reach and deepen their collaboration within the network. Specific areas of focus included:
💡 Leveraging mRNA platforms for broader applications
🌍 Expanding distribution, particularly to Africa
📈 Enhancing product readiness for international procurement
🔬 Improving data to meet global regulatory standards
Mr. Suri shared valuable insights on accessing funding and identifying strategic manufacturing partners, reinforcing DCVMN’s role as a bridge between innovation, collaboration, and global health equity.
Additionally, DCVMN was pleased to engage with LakeShore Biopharma Co., Ltd., who expressed strong interest in becoming part of our growing network.
These discussions reaffirm our commitment to ensuring that DCVMN remains a responsive and reliable partner, advocating for our members and supporting their path to becoming active players in the global vaccine landscape.
DCVMN, We Connect to Protect!
